Advisors Capital Management LLC grew its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 20.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,232,609 shares of the real estate investment trust's stock after purchasing an additional 380,505 shares during the period. Advisors Capital Management LLC owned about 0.94% of Sabra Healthcare REIT worth $39,004,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in SBRA. Ameriprise Financial Inc. lifted its stake in Sabra Healthcare REIT by 6.9% during the fourth quarter. Ameriprise Financial Inc. now owns 912,210 shares of the real estate investment trust's stock worth $15,799,000 after purchasing an additional 58,919 shares during the last quarter. D. E. Shaw & Co. Inc. boosted its holdings in Sabra Healthcare REIT by 749.3% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 221,992 shares of the real estate investment trust's stock valued at $3,845,000 after acquiring an additional 195,854 shares during the period. Focus Partners Wealth increased its stake in Sabra Healthcare REIT by 4.0% in the 4th quarter. Focus Partners Wealth now owns 20,771 shares of the real estate investment trust's stock worth $360,000 after purchasing an additional 797 shares during the period. Jefferies Financial Group Inc. purchased a new position in Sabra Healthcare REIT in the 4th quarter worth approximately $348,000. Finally, Janus Henderson Group PLC lifted its position in Sabra Healthcare REIT by 23.1% in the fourth quarter. Janus Henderson Group PLC now owns 3,504,809 shares of the real estate investment trust's stock valued at $60,720,000 after purchasing an additional 657,950 shares during the last quarter. Institutional investors own 99.40% of the company's stock.
Sabra Healthcare REIT Trading Down 1.1%
SBRA traded down $0.21 on Tuesday, hitting $18.98. The company had a trading volume of 579,713 shares, compared to its average volume of 2,421,306. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The company has a market cap of $4.55 billion, a PE ratio of 24.98, a PEG ratio of 1.52 and a beta of 0.88. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $20.03. The business's fifty day simple moving average is $18.70 and its 200 day simple moving average is $18.01.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.02. The business had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm's quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.
Sabra Healthcare REIT Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.3%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT's payout ratio is currently 157.89%.
Analyst Ratings Changes
Several analysts have weighed in on the company. Truist Financial boosted their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a research report on Tuesday, September 2nd. BMO Capital Markets boosted their price objective on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research report on Monday, August 25th. Wells Fargo & Company boosted their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research report on Wednesday, August 27th. JMP Securities boosted their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research report on Wednesday, August 6th. Finally, Scotiabank boosted their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a report on Monday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, Sabra Healthcare REIT has a consensus rating of "Moderate Buy" and a consensus target price of $20.83.
Get Our Latest Report on Sabra Healthcare REIT
Sabra Healthcare REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Further Reading

Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.